ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Parathyroid Hormone Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-13P15302
Home | Market Reports | Science| Biological Sciences
Global Recombinant Human Parathyroid Hormone Market Research Report 2023
BUY CHAPTERS

Global Recombinant Human Parathyroid Hormone Market Research Report 2025

Code: QYRE-Auto-13P15302
Report
May 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda
Ascendis Pharma
Beijing SL Pharmaceutical
NPS Pharma(Shire)
Shandong Buchang Pharmaceuticals

Recombinant Human Parathyroid Hormone Market Size

The global market for Recombinant Human Parathyroid Hormone was valued at US$ 163 million in the year 2024 and is projected to reach a revised size of US$ 257 million by 2031, growing at a CAGR of 6.8% during the forecast period.

Recombinant Human Parathyroid Hormone Market

Recombinant Human Parathyroid Hormone Market

Recombinant Human Parathyroid Hormone is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism. Recombinant human parathyroid hormone is used in the treatment of osteoporosis in postmenopausal women at high risk of osteoporotic fractures. A significant reduction in the incidence of vertebral fractures has been demonstrated.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Parathyroid Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Parathyroid Hormone.
The Recombinant Human Parathyroid Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Parathyroid Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Parathyroid Hormone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Human Parathyroid Hormone Market Report

Report Metric Details
Report Name Recombinant Human Parathyroid Hormone Market
Accounted market size in year US$ 163 million
Forecasted market size in 2031 US$ 257 million
CAGR 6.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 25 mcg/dose
  • 50 mcg/dose
  • 75 mcg/dose
  • 100 mcg/dose
Segment by Application
  • Postmenopausal Women with Osteoporosis
  • Hypocalcemia in Patients with Hypoparathyroidism
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company NPS Pharma(Shire), Takeda, Shandong Buchang Pharmaceuticals, Ascendis Pharma, Beijing SL Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Human Parathyroid Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Human Parathyroid Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Recombinant Human Parathyroid Hormone Market growing?

Ans: The Recombinant Human Parathyroid Hormone Market witnessing a CAGR of 6.8% during the forecast period 2025-2031.

What is the Recombinant Human Parathyroid Hormone Market size in 2031?

Ans: The Recombinant Human Parathyroid Hormone Market size in 2031 will be US$ 257 million.

Who are the main players in the Recombinant Human Parathyroid Hormone Market report?

Ans: The main players in the Recombinant Human Parathyroid Hormone Market are NPS Pharma(Shire), Takeda, Shandong Buchang Pharmaceuticals, Ascendis Pharma, Beijing SL Pharmaceutical

What are the Application segmentation covered in the Recombinant Human Parathyroid Hormone Market report?

Ans: The Applications covered in the Recombinant Human Parathyroid Hormone Market report are Postmenopausal Women with Osteoporosis, Hypocalcemia in Patients with Hypoparathyroidism

What are the Type segmentation covered in the Recombinant Human Parathyroid Hormone Market report?

Ans: The Types covered in the Recombinant Human Parathyroid Hormone Market report are 25 mcg/dose, 50 mcg/dose, 75 mcg/dose, 100 mcg/dose

Recommended Reports

Hormonal Therapies

Bone Disorders

Protein & Recombinants

1 Recombinant Human Parathyroid Hormone Market Overview
1.1 Product Definition
1.2 Recombinant Human Parathyroid Hormone by Type
1.2.1 Global Recombinant Human Parathyroid Hormone Market Value Comparison by Type (2024 VS 2031)
1.2.2 25 mcg/dose
1.2.3 50 mcg/dose
1.2.4 75 mcg/dose
1.2.5 100 mcg/dose
1.3 Recombinant Human Parathyroid Hormone by Application
1.3.1 Global Recombinant Human Parathyroid Hormone Market Value by Application (2024 VS 2031)
1.3.2 Postmenopausal Women with Osteoporosis
1.3.3 Hypocalcemia in Patients with Hypoparathyroidism
1.4 Global Recombinant Human Parathyroid Hormone Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Parathyroid Hormone Revenue 2020-2031
1.4.2 Global Recombinant Human Parathyroid Hormone Sales 2020-2031
1.4.3 Global Recombinant Human Parathyroid Hormone Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Human Parathyroid Hormone Market Competition by Manufacturers
2.1 Global Recombinant Human Parathyroid Hormone Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Human Parathyroid Hormone Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Human Parathyroid Hormone, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Parathyroid Hormone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Parathyroid Hormone, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Human Parathyroid Hormone, Date of Enter into This Industry
2.8 Global Recombinant Human Parathyroid Hormone Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Parathyroid Hormone Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Human Parathyroid Hormone Players Market Share by Revenue
2.8.3 Global Recombinant Human Parathyroid Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Parathyroid Hormone Market Scenario by Region
3.1 Global Recombinant Human Parathyroid Hormone Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Human Parathyroid Hormone Sales by Region: 2020-2031
3.2.1 Global Recombinant Human Parathyroid Hormone Sales by Region: 2020-2025
3.2.2 Global Recombinant Human Parathyroid Hormone Sales by Region: 2026-2031
3.3 Global Recombinant Human Parathyroid Hormone Revenue by Region: 2020-2031
3.3.1 Global Recombinant Human Parathyroid Hormone Revenue by Region: 2020-2025
3.3.2 Global Recombinant Human Parathyroid Hormone Revenue by Region: 2026-2031
3.4 North America Recombinant Human Parathyroid Hormone Market Facts & Figures by Country
3.4.1 North America Recombinant Human Parathyroid Hormone Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Human Parathyroid Hormone Sales by Country (2020-2031)
3.4.3 North America Recombinant Human Parathyroid Hormone Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Parathyroid Hormone Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Parathyroid Hormone Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Human Parathyroid Hormone Sales by Country (2020-2031)
3.5.3 Europe Recombinant Human Parathyroid Hormone Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Parathyroid Hormone Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Parathyroid Hormone Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Human Parathyroid Hormone Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Human Parathyroid Hormone Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Parathyroid Hormone Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Parathyroid Hormone Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Human Parathyroid Hormone Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Human Parathyroid Hormone Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human Parathyroid Hormone Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Parathyroid Hormone Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Human Parathyroid Hormone Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Parathyroid Hormone Sales by Type (2020-2031)
4.1.1 Global Recombinant Human Parathyroid Hormone Sales by Type (2020-2025)
4.1.2 Global Recombinant Human Parathyroid Hormone Sales by Type (2026-2031)
4.1.3 Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Human Parathyroid Hormone Revenue by Type (2020-2031)
4.2.1 Global Recombinant Human Parathyroid Hormone Revenue by Type (2020-2025)
4.2.2 Global Recombinant Human Parathyroid Hormone Revenue by Type (2026-2031)
4.2.3 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Human Parathyroid Hormone Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Human Parathyroid Hormone Sales by Application (2020-2031)
5.1.1 Global Recombinant Human Parathyroid Hormone Sales by Application (2020-2025)
5.1.2 Global Recombinant Human Parathyroid Hormone Sales by Application (2026-2031)
5.1.3 Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Human Parathyroid Hormone Revenue by Application (2020-2031)
5.2.1 Global Recombinant Human Parathyroid Hormone Revenue by Application (2020-2025)
5.2.2 Global Recombinant Human Parathyroid Hormone Revenue by Application (2026-2031)
5.2.3 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Human Parathyroid Hormone Price by Application (2020-2031)
6 Key Companies Profiled
6.1 NPS Pharma(Shire)
6.1.1 NPS Pharma(Shire) Company Information
6.1.2 NPS Pharma(Shire) Description and Business Overview
6.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2020-2025)
6.1.4 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Portfolio
6.1.5 NPS Pharma(Shire) Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Company Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Takeda Recombinant Human Parathyroid Hormone Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Shandong Buchang Pharmaceuticals
6.3.1 Shandong Buchang Pharmaceuticals Company Information
6.3.2 Shandong Buchang Pharmaceuticals Description and Business Overview
6.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Portfolio
6.3.5 Shandong Buchang Pharmaceuticals Recent Developments/Updates
6.4 Ascendis Pharma
6.4.1 Ascendis Pharma Company Information
6.4.2 Ascendis Pharma Description and Business Overview
6.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ascendis Pharma Recombinant Human Parathyroid Hormone Product Portfolio
6.4.5 Ascendis Pharma Recent Developments/Updates
6.5 Beijing SL Pharmaceutical
6.5.1 Beijing SL Pharmaceutical Company Information
6.5.2 Beijing SL Pharmaceutical Description and Business Overview
6.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Portfolio
6.5.5 Beijing SL Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Parathyroid Hormone Industry Chain Analysis
7.2 Recombinant Human Parathyroid Hormone Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Parathyroid Hormone Production Mode & Process Analysis
7.4 Recombinant Human Parathyroid Hormone Sales and Marketing
7.4.1 Recombinant Human Parathyroid Hormone Sales Channels
7.4.2 Recombinant Human Parathyroid Hormone Distributors
7.5 Recombinant Human Parathyroid Hormone Customer Analysis
8 Recombinant Human Parathyroid Hormone Market Dynamics
8.1 Recombinant Human Parathyroid Hormone Industry Trends
8.2 Recombinant Human Parathyroid Hormone Market Drivers
8.3 Recombinant Human Parathyroid Hormone Market Challenges
8.4 Recombinant Human Parathyroid Hormone Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Takeda
Ascendis Pharma
Beijing SL Pharmaceutical
NPS Pharma(Shire)
Shandong Buchang Pharmaceuticals
List of Tables
 Table 1. Global Recombinant Human Parathyroid Hormone Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Human Parathyroid Hormone Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Human Parathyroid Hormone Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Human Parathyroid Hormone Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Human Parathyroid Hormone Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Human Parathyroid Hormone Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Human Parathyroid Hormone Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Human Parathyroid Hormone Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Human Parathyroid Hormone, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Human Parathyroid Hormone, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Human Parathyroid Hormone, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Human Parathyroid Hormone, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Human Parathyroid Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Parathyroid Hormone as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Human Parathyroid Hormone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Human Parathyroid Hormone Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Human Parathyroid Hormone Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Human Parathyroid Hormone Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Human Parathyroid Hormone Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Human Parathyroid Hormone Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Human Parathyroid Hormone Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Human Parathyroid Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Human Parathyroid Hormone Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Human Parathyroid Hormone Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Human Parathyroid Hormone Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Human Parathyroid Hormone Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Human Parathyroid Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Human Parathyroid Hormone Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Human Parathyroid Hormone Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Human Parathyroid Hormone Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Human Parathyroid Hormone Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Human Parathyroid Hormone Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Human Parathyroid Hormone Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Human Parathyroid Hormone Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Human Parathyroid Hormone Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Human Parathyroid Hormone Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Human Parathyroid Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Human Parathyroid Hormone Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Human Parathyroid Hormone Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Human Parathyroid Hormone Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Human Parathyroid Hormone Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Human Parathyroid Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Human Parathyroid Hormone Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Human Parathyroid Hormone Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Human Parathyroid Hormone Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Human Parathyroid Hormone Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Human Parathyroid Hormone Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Human Parathyroid Hormone Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Human Parathyroid Hormone Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Human Parathyroid Hormone Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Human Parathyroid Hormone Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Human Parathyroid Hormone Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Human Parathyroid Hormone Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Human Parathyroid Hormone Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Human Parathyroid Hormone Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Human Parathyroid Hormone Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Human Parathyroid Hormone Price (US$/Unit) by Application (2026-2031)
 Table 70. NPS Pharma(Shire) Company Information
 Table 71. NPS Pharma(Shire) Description and Business Overview
 Table 72. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product
 Table 74. NPS Pharma(Shire) Recent Developments/Updates
 Table 75. Takeda Company Information
 Table 76. Takeda Description and Business Overview
 Table 77. Takeda Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Takeda Recombinant Human Parathyroid Hormone Product
 Table 79. Takeda Recent Developments/Updates
 Table 80. Shandong Buchang Pharmaceuticals Company Information
 Table 81. Shandong Buchang Pharmaceuticals Description and Business Overview
 Table 82. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product
 Table 84. Shandong Buchang Pharmaceuticals Recent Developments/Updates
 Table 85. Ascendis Pharma Company Information
 Table 86. Ascendis Pharma Description and Business Overview
 Table 87. Ascendis Pharma Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ascendis Pharma Recombinant Human Parathyroid Hormone Product
 Table 89. Ascendis Pharma Recent Developments/Updates
 Table 90. Beijing SL Pharmaceutical Company Information
 Table 91. Beijing SL Pharmaceutical Description and Business Overview
 Table 92. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product
 Table 94. Beijing SL Pharmaceutical Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Recombinant Human Parathyroid Hormone Distributors List
 Table 98. Recombinant Human Parathyroid Hormone Customers List
 Table 99. Recombinant Human Parathyroid Hormone Market Trends
 Table 100. Recombinant Human Parathyroid Hormone Market Drivers
 Table 101. Recombinant Human Parathyroid Hormone Market Challenges
 Table 102. Recombinant Human Parathyroid Hormone Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Human Parathyroid Hormone
 Figure 2. Global Recombinant Human Parathyroid Hormone Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Human Parathyroid Hormone Market Share by Type: 2024 & 2031
 Figure 4. 25 mcg/dose Product Picture
 Figure 5. 50 mcg/dose Product Picture
 Figure 6. 75 mcg/dose Product Picture
 Figure 7. 100 mcg/dose Product Picture
 Figure 8. Global Recombinant Human Parathyroid Hormone Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Recombinant Human Parathyroid Hormone Market Share by Application: 2024 & 2031
 Figure 10. Postmenopausal Women with Osteoporosis
 Figure 11. Hypocalcemia in Patients with Hypoparathyroidism
 Figure 12. Global Recombinant Human Parathyroid Hormone Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Recombinant Human Parathyroid Hormone Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Recombinant Human Parathyroid Hormone Sales (2020-2031) & (K Units)
 Figure 15. Global Recombinant Human Parathyroid Hormone Average Price (US$/Unit) & (2020-2031)
 Figure 16. Recombinant Human Parathyroid Hormone Report Years Considered
 Figure 17. Recombinant Human Parathyroid Hormone Sales Share by Manufacturers in 2024
 Figure 18. Global Recombinant Human Parathyroid Hormone Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Recombinant Human Parathyroid Hormone Players: Market Share by Revenue in Recombinant Human Parathyroid Hormone in 2024
 Figure 20. Recombinant Human Parathyroid Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Recombinant Human Parathyroid Hormone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Recombinant Human Parathyroid Hormone Sales Market Share by Country (2020-2031)
 Figure 23. North America Recombinant Human Parathyroid Hormone Revenue Market Share by Country (2020-2031)
 Figure 24. United States Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Recombinant Human Parathyroid Hormone Sales Market Share by Country (2020-2031)
 Figure 27. Europe Recombinant Human Parathyroid Hormone Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Recombinant Human Parathyroid Hormone Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Recombinant Human Parathyroid Hormone Revenue Market Share by Region (2020-2031)
 Figure 35. China Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Recombinant Human Parathyroid Hormone Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Recombinant Human Parathyroid Hormone Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Recombinant Human Parathyroid Hormone Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Recombinant Human Parathyroid Hormone Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Recombinant Human Parathyroid Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Recombinant Human Parathyroid Hormone by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Recombinant Human Parathyroid Hormone by Type (2020-2031)
 Figure 54. Global Recombinant Human Parathyroid Hormone Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Recombinant Human Parathyroid Hormone by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Recombinant Human Parathyroid Hormone by Application (2020-2031)
 Figure 57. Global Recombinant Human Parathyroid Hormone Price (US$/Unit) by Application (2020-2031)
 Figure 58. Recombinant Human Parathyroid Hormone Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Recombinant Hormone Market Research Report 2024
Global Teriparatide Acetate Market Research Report 2024
Global Recombinant Growth Hormone Market Research Report 2024
Global Recombinant Human Somatropin for Injection Market Research Report 2024
Global Recombinant Human Growth Hormone Market Research Report 2025
Global Recombinant Human BMP 2 Market Research Report 2024
Recombinant Human Follicle stimulating Hormone Market
Human Intact PTH ELISA Test Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Growth Hormone Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Human Osteopontin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Secondary Hyperparathyroidism Drug Market Research Report 2025
Recombinant Follicle Stimulating Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Transforming Growth Factor β Market Research Report 2024
Global Parathyroid Hormone ELISA Test Kit Market Research Report 2024
Global Recombinant Protein Peptide Drug Market Research Report 2024
Hypoparathyroidism Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Human Chorionic Gonadotropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hormone Replacement Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intact PTH ELISA Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Treatment of Parathyroid Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions